Coronary Artery Bypass: Clinical Trials

4 trials for Coronary Artery Bypass, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4

Follow Coronary Artery Bypass: new trials by email Literature Review of Coronary Artery Bypass trials Research Report on Coronary Artery Bypass

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting
Roxadustat, Placebo - Coronary Artery Bypass
Phase 2TerminatedPeking Union Medical College Hospital982021-09-302025-12-09
Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)
AVI-5126 - Cardiovascular Disease, Coronary Artery Bypass
Phase 2TerminatedSarepta Therapeutics, Inc.6002007-03-012009-07-08
A Retrospective Analysis of the Predictive Potential of Pre-operative
Atrial Fibrillation - Coronary Artery Bypass
Phase 2TerminatedEmory University6002006-02-012013-09-27
Training Intensity After Coronary Bypass Grafting
Exercise training - Coronary Artery Bypass
Phase 2TerminatedNorwegian University of Science and Technology602004-03-012010-05-18

Narrower conditions

Acute Kidney Injury (1)  ·  Atrial Fibrillation (1)  ·  Cardiovascular Diseases (1)

Broader conditions

Arrhythmias, Cardiac (1)  ·  Cardiovascular Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Heart Diseases (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

AVI-5126 (1)  ·  Exercise (1)  ·  roxadustat (1)

Sponsors

Emory University (1)  ·  Norwegian University of Science and Technology (1)  ·  Peking Union Medical College Hospital (1)  ·  Sarepta Therapeutics, Inc. (1)

Countries

China (1)  ·  Norway (1)  ·  Ukraine (1)  ·  United States (1)

Top investigators

Qi Miao, Doctor (1)  ·  Samuel C. Dudley, Jr., MD, PhD (1)  ·  Trine T Moholdt, MS (1)  ·  Yan Qin, Doctor (1)